91 studies found for:    MMP-9
Show Display Options
Rank Status Study
1 Completed MMP-9 Monitoring Particulate Cerebral Embolisation
Condition: Cerebral Embolic Damage
Intervention: Procedure: vein blood collection
2 Recruiting Multicentre Trial Of Serum Levels Of MMP-9 As A Biomarker Of Endoleak
Condition: Endoleak After Endovascular Aneurysm Repair
Intervention:
3 Not yet recruiting The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels
Condition: Cerebral Infarction
Interventions: Drug: Erigeron Injection;   Drug: placebo
4 Recruiting Biomarkers for Prognosis of Glioblastoma (GBM)
Condition: Glioblastoma
Intervention:
5 Completed Trial of Doxycycline to Reduce Sputum MMP-9 Activity in Adult Cystic Fibrosis (CF) Patients
Condition: Cystic Fibrosis
Interventions: Drug: Doxycycline;   Other: placebo
6 Completed Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma?
Condition: Glaucoma
Intervention: Procedure: Blood Sample
7 Unknown  Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia
Condition: Schizophrenia
Intervention: Dietary Supplement: Sarcosine
8 Completed
Has Results
Extracellular Matrix Marker of Arrhythmia Risk (EMMA)
Conditions: Myocardiopathies;   Ischemia, Myocardial;   Arrythmia;   Death, Sudden, Cardiac
Intervention:
9 Completed Influence of MMP on Brain AVM Hemorrhage
Conditions: Arteriovenous Malformations;   Cavernous Angiomas;   Brain Aneurysms
Intervention: Drug: Doxycycline or Placebo
10 Completed Effect of Montelukast on Remodelling Markers in Asthmatic Children
Condition: Asthma
Interventions: Drug: Montelukast;   Drug: placebo
11 Completed
Has Results
Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression
Condition: HIV Infections
Intervention: Drug: Maraviroc
12 Completed Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients.
Condition: Prostate Cancer
Intervention: Drug: PCK3145
13 Completed
Has Results
Periodontal Infection and Endothelial Dysfunction
Condition: Periodontitis
Interventions: Procedure: One-Stage Full-Mouth Disinfection;   Procedure: Periodontal care
14 Recruiting Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease
Conditions: Type 2 Diabetes Mellitus;   Ischemic Heart Disease
Interventions: Drug: Metformin plus vildagliptin;   Drug: Metformin only
15 Completed Study to Determine the Ability of Seresis to Act as a Skin Protection Agent in Healthy Young Female Volunteers
Condition: Healthy
Interventions: Drug: Seresis®;   Drug: Placebo
16 Unknown  Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
Condition: Head and Neck Cancer
Interventions: Drug: celecoxib;   Genetic: microarray analysis;   Genetic: protein expression analysis;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: biopsy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
17 Completed A Comparative Study of Volume Replacement With HES 130/0.4 Versus Ringer's Lactate (RL) Regarding Their Effects on Inflammatory Biomarkers (Cytokines and Matrix Metalloproteinases) Responses to Major Abdominal Surgery.
Condition: Postoperative Inflammation
Interventions: Other: Ringer's Lactate;   Other: HES 130/0.4 and Ringer's Lactate
18 Completed Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes
Condition: Diabetes Mellitus
Interventions: Drug: Insulin Glulisine;   Drug: Insulin
19 Completed
Has Results
EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA
Condition: Cerebrovascular Accident
Interventions: Drug: Aggrenox bid (ASA 25mg/Dipyridamole ER 200mg);   Drug: ASA 100 mg qd
20 Completed Matrix Metalloproteinase-1/Tissue Inhibitor of Metalloproteinase-1 (MMP-1/TIMP-1) Ratio and Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Intervention: Other: Picture + MMPs and TIMP1 at week 0 and week 4

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years